Sexually transmitted diseases during pregnancy: screening, diagnostic, and treatment practices among prenatal care providers in Georgia
Weisbord, J.S.; Koumans, E.H.; Toomey, K.E.; Grayson, C.; Markowitz, L.E.
Southern Medical Journal 94(1): 47-53
2001
ISSN/ISBN: 0038-4348 PMID: 11213942 Document Number: 539508
Background. Sexually transmitted diseases (STD) during pregnancy are associated with adverse outcomes. We conducted a prenatal care provider survey to determine STD screening, diagnosis, and treatment practices. Methods. Standard questionnaires were mailed to Georgia-licensed obstetrician/gynecologists, family practitioners, and nurse-midwives (N = 3,082) in 1998. Results. Of the 1,300 care providers who returned the survey, 565 (44%) provided prenatal care, 390 (57%) were male, and 396 (70%) were obstetrician/gynecologists. Overall, 553 prenatal care providers (98%) reported screening all pregnant patients for syphilis, 551 (98%) for hepatitis B, 501 (89%) for trichomonas, 474 (84%) for human immunodeficiency virus (HIV), 401 (71%) for gonorrhea, 403 (71%) for chlamydia, 475 (84%) for group B streptococci, and 130 (23%) for bacterial vaginosis (BV) (high risk). Less than 10% used amplification tests for chlamydia or gonorrhea. Most providers used appropriate regimens to treat STD in pregnant women. A written office policy on testing for BV or HIV was associated with increased screening. Conclusions. Provider education is needed about diagnosis and treatment of STD during pregnancy.